Surgery Partners Inc’s filing revealed that its Chief Admin & Dev Officer Baldock Jennifer unloaded Company’s shares for reported $14651.0 on Mar 14 ’25. In the deal valued at $23.94 per share,612 shares were sold. As a result of this transaction, Baldock Jennifer now holds 236,047 shares worth roughly $5.75 million.
Then, Burkhalter Danielle sold 74 shares, generating $1,760 in total proceeds. Upon selling the shares at $23.78, the Chief Human Resources Officer now owns 44,839 shares.
Before that, Webb William Trenton sold 138 shares. Surgery Partners Inc shares valued at $3,271 were divested by the American Group President at a price of $23.70 per share. As a result of the transaction, Webb William Trenton now holds 74,521 shares, worth roughly $1.82 million.
BofA Securities initiated its Surgery Partners Inc [SGRY] rating to a Buy in a research note published on December 16, 2024; the price target was $30. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. KeyBanc Capital Markets began covering SGRY with “Sector weight” recommendation on October 11, 2024. Macquarie started covering the stock on June 28, 2024. It rated SGRY as “an Outperform”.
Price Performance Review of SGRY
On Tuesday, Surgery Partners Inc [NASDAQ:SGRY] saw its stock fall -0.12% to $24.37. Over the last five days, the stock has gained 3.13%. Surgery Partners Inc shares have risen nearly 15.12% since the year began. Nevertheless, the stocks have fallen -15.23% over the past one year. While a 52-week high of $33.97 was reached on 02/14/25, a 52-week low of $19.50 was recorded on 01/14/25. SMA at 50 days reached $23.63, while 200 days put it at $26.51.
Levels Of Support And Resistance For SGRY Stock
The 24-hour chart illustrates a support level at 24.20, which if violated will result in even more drops to 24.03. On the upside, there is a resistance level at 24.53. A further resistance level may holdings at 24.69. The Relative Strength Index (RSI) on the 14-day chart is 52.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 42.75%. Stochastics %K at 42.11% indicates the stock is a holding.
How much short interest is there in Surgery Partners Inc?
A steep rise in short interest was recorded in Surgery Partners Inc stocks on 2025-02-28, growing by 0.52 million shares to a total of 9.98 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 9.45 million shares. There was a rise of 5.26%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 06, 2024 when Barclays began covering the stock and recommended ‘”an Equal weight”‘ rating along with a $35 price target.
